HOME >> MEDICINE >> NEWS
New study: Pycnogenol reduces heart failure

A study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart. The study demonstrates Pycnogenol counteracts the "wearing out" of the heart, which may aid the five million Americans living with heart failure. Previous studies have shown Pycnogenol supplementation to be associated with improved cardiovascular health, such as cholesterol reduction, blood pressure control and prevention of thrombosis.

In hypertension, the over-worked heart gradually wears out, resulting in the weakening of the heart muscle and increasing of heart chamber volume. This process (known as cardiac remodeling) may eventually cause heart failure when the heart insufficiently supplies the body with oxygenated blood. The study showed that Pycnogenol prevents the heart from getting worn out during hypertension. Cardiac chamber walls showed a significantly higher rate of collagen connective tissues than control groups.

"Alternative treatments such as Pycnogenol are crucial components in the fight against heart disease,"said Dr. Ronald Watson, professor in the Department of Nutritional Sciences at the University of Arizona and a lead researcher of the study. "The effectiveness of Pycnogenol supplementation is a great option for many people who want an alternative to prescription medications such as beta blockers or ACE inhibitors. This new study shows Pycnogenol administers a therapeutic effect to limit the degenerative process in patients predisposed to congestive heart failure, such as the aged."

The study was conducted at the University of Arizona, Tucson. Elderly female mice (18 months old) were randomly divided into four groups: control mice, mice receiving Pycnogenol only, mice receiving L-NAME only (a substance which causes arterial constriction) and mice receiving both Pycnogenol
'"/>

Contact: Melanie Nimrodi
mnimrodi@mww.com
312-546-3508
MWW Group
16-May-2007


Page: 1 2 3

Related medicine news :

1. HealthGrades study: Bariatric surgery patients have fewer complications at high-volume hospitals
2. Case study: cross-cultural bioethics training program helps fight African brain drain
3. New study: Pine bark significantly reduces endometriosis
4. FSU study: Can prunes reverse bone loss after menopause?
5. New study: Preterm birth causes one-third of all infant deaths
6. FSU study: Abortion notification, consent laws reduce risky teen sex
7. National study: Patients poorly prepared for end-of-life decisions
8. UCLA/VA study: Many patients not receiving follow-up tests after positive screening for colon cancer
9. U-M study: Program to boost elderly flu vaccination could save lives
10. Loyola study: Telemetry captures stroke patients cardiac problems
11. Mayo Clinic study: People with heart failure at significant increase for death from stroke

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... Ontario (PRWEB) , ... August 07, 2020 , ... ... the AGCO with the assistance of dicentra Cannabis Consulting . , The ... on May 31st. It is the first of many locations as the company plans ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... repeatedly risen to unprecedented challenges. Regardless of the obstacle - shortages of tests, ... equipment (PPE) and the cancellation or postponement of all nonessential services - providers ...
(Date:8/5/2020)... ... ... CentrAlert, Inc. today announced the launch of their free Know ... which is available for Apple and Android , seeks to streamline ... , “When COVID-19 first hit, there was so much that we didn’t know,” says ...
(Date:8/5/2020)... ... ... Today, Power to Decide’s One Key Question was recognized by the Association ... Award. The One Key Question program is a transformative tool that starts the conversation ... One Key Question is used by thousands of health care, social service providers and ...
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate ... first patients with first-line advanced pancreatic cancer in a phase 2 study of ... 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 ...
Breaking Medicine News(10 mins):
(Date:8/5/2020)... ROCKVILLE, Md. (PRWEB) , ... August 04, 2020 ... ... audiology and speech-language pathology therapy services vital to their health and quality of ... to protect them, the American Speech-Language-Hearing Association (ASHA) warns today. ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... Business Continuity Emergency Operations Planning services for small business owners. These ... unable to manage or communicate with their teams for 30-90 days as a ...
(Date:7/31/2020)... ... July 31, 2020 , ... Innovative Health, Inc. ... Medical BRK Transseptal Needle and the Baylis Medical NRG Transseptal Needle. Innovative Health’s ... reprocessing, as no other company is able to offer reprocessed transseptal needles and ...
Breaking Medicine Technology:
Cached News: